title: VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
authors.forename: George L
authors.initials: GL
authors.lastname: Daikos
authors.forename: Andreas
authors.initials: A
authors.lastname: Karabinis
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Paramythiotou
authors.forename: Vassiliki P
authors.initials: VP
authors.lastname: Syriopoulou
authors.forename: Christos
authors.initials: C
authors.lastname: Kosmidis
authors.forename: Athina
authors.initials: A
authors.lastname: Avlami
authors.forename: Panayiotis
authors.initials: P
authors.lastname: Gargalianos
authors.forename: Konstantina
authors.initials: K
authors.lastname: Tzanetou
authors.forename: Demetra
authors.initials: D
authors.lastname: Petropoulou
authors.forename: Helen
authors.initials: H
authors.lastname: Malamou-Lada
mesh_terms: D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015378:Imipenem / Q000494:pharmacology / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology* / Q000401:mortality; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000472:pathogenicity; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012044:Regression Analysis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000187:drug effects / Q000235:genetics
chemical_list: D015378:Imipenem; C417264:VIM-1 metallo-beta-lactamase; D001618:beta-Lactamases